Although the inhibition of rechallenge tumor growth suggests that CD8+ T cells were present, the ultimate goal is to stimulate the immune system to a degree that eliminates tumor cells outside of the immediate ablation zone. The gene discussed is CD8A; the disease is neoplasm.